CLOs on the Move

Veristat

www.veristat.com

 
Veristat, a global clinical research organization (CRO), enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval. With more than 26 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program. Our team has prepared over 100 marketing applications for approval with global regulatory authorities in the last 10 years.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.veristat.com
  • 134 Turnpike Road Suite 200
    Southborough, MA USA 01772
  • Phone: 508.429.7340

Executives

Name Title Contact Details
Mark Ammann
Senior Vice President, Regulatory Affairs Profile
Mara Gladstone Holinger
Vice President of Regulatory Affairs Profile

Similar Companies

Pharmascent

Pharmascent is a Denver, CO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

University Compounding Pharmacy

University Compounding Pharmacy is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

S A Scientific

S A Scientific is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Montana Health Research Inst

Montana Health Research Inst is a Billings, MT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Spectrum Pharmaceuticals

Spectrum`s core mission is to bring pharmaceutical products to patients for unmet medical needs. To this mission, we bring our years of drug development expertise, coupled with the insight of working in many different oncology indications. Spectrum and its subsidiaries have six marketed oncology/hematology products, three for different types of non-Hodgkins lymphoma, one for advanced metastatic colorectal cancer, one for a certain type of acute lymphoblastic leukemia (ALL) and one for multiple myeloma. There are two products in late-stage development, as well as a broad and diversified portfolio of proprietary drugs in various stages of development, all with a focus on oncology and hematology.